FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 344:1939-1942 June 21, 2001 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Cannon, C. P. Related Article by Topol, E. J. Related Article by Montalescot, G. PubMed Citation

The management of acute coronary syndromes has evolved rapidly over the past decade and continues to do so. Three studies on this topic appear in this issue of the Journal. They are the Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy–Thrombolysis in Myocardial Infarction 18 (TACTICS–TIMI 18) trial,¹ the Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long-Term Follow-up (ADMIRAL) trial,² and the Do Tirofiban and ReoPro Give Similar Efficacy Trial (TARGET).³ All three provide new information about the relative merits of pharmacologic therapy and percutaneous coronary intervention, . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Authors/Task Force Members, , Silber, S., Albertsson, P., Aviles, F. F., Camici, P. G., Colombo, A., Hamm, C., Jorgensen, E., Marco, J., Nordrehaug, J.-E., Ruzyllo, W., Urban, P., Stone, G. W., Wijns, W. (2005). Guidelines for Percutaneous Coronary Interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26: 804-847 [Full Text]  
• Chiu, C. W., So, N. M. C., Lam, W. W. M., Chan, K. Y., Sanderson, J. E. (2003). Combined First-Pass Perfusion and Viability Study at MR Imaging in Patients with Non-ST Segment-Elevation Acute Coronary Syndromes: Feasibility Study. Radiology 226: 717-722 [Abstract] [Full Text]  
• Boden, W. E., Pepine, C. J. (2003). Introduction to "optimizing management of non-ST-segment elevation acute coronary syndromes": Harmonizing advances in mechanical and pharmacologic intervention. J Am Coll Cardiol 41: 1S-6S [Full Text]  
• Boden, W. E. (2003). "Routine invasive" versus "selective invasive" approaches to non-ST-segment elevation acute coronary syndromes management in the post-stent/platelet inhibition era. J Am Coll Cardiol 41: 113S-122S [Abstract] [Full Text]  
• Moliterno, D.J., Topol, E.J. (2002). The TARGET trial: hit or miss?. Eur Heart J 23: 835-837 [Full Text]  
• Goyal, A., Samaha, F. F., Boden, W. E., Wade, M. J., Kimmel, S. E. (2002). Stress test criteria used in the conservative arm of the frisc-ii trial underdetects surgical coronary artery disease whenapplied to patients in the vanqwish trial. J Am Coll Cardiol 39: 1601-1607 [Abstract] [Full Text]  
• Baumbach, A., Karsch, K. R. (2002). Pricing a year of life: a necessary exercise in modern health care. Eur Heart J 23: 5-7 [Full Text]  
• (2001). Cath Lab for All Patients with Unstable Angina or Non-ST-Segment Elevation MI?. JWatch General 2001: 1-1 [Full Text]  
• (2001). Are All Glycoprotein IIb/IIIa Inhibitors Equivalent?. JWatch General 2001: 3-3 [Full Text]